EGFR

You have access
PD-L1 as a Biomarker for the Efficacy of Durvalumab in Stage III EGFR Mutant NSCLC
INSU KIM, SUN HA CHOI, SHIN YUP LEE, SEUNG SOO YOO, JI EUN PARK, KYEONG-CHEOL SHIN, JONG GEOL JANG, KYUNG SOO HONG, YONG SHIK KWON, SUN HYO PARK, KEUM-JU CHOI, CHI YOUNG JUNG, MI-HYUN KIM, SOO HAN KIM, HEE YUN SEOL, JEHUN KIM, JIN-HAN PARK, TAE HOON KIM, JUNG SEOP EOM and JUNE HONG AHN

Anticancer Research October 2024, 44 (10) 4505-4516; DOI: https://doi.org/10.21873/anticanres.17279
You have access
Functional Role of DUSP6 in the EGFR-mediated Progression of Head and Neck Squamous Cell Carcinoma
CHEN-HAN TAI, CHIH-CHUN WANG, YU-CHEN SHIH, YUN-JU CHEN, BEN-KUEN CHEN and LEI-CHIN CHEN

Anticancer Research June 2024, 44 (6) 2545-2554; DOI: https://doi.org/10.21873/anticanres.17060
You have access
Design and Evaluation of a Humanized Anti-EGFR huscFv Antibody Fragment in Combination With Metformin in A549 Cells In Vitro
JORGE SOLIS-ESTRADA, EDER ARREDONDO-ESPINOZA, ELIZETH PIOQUINTO-ÁVILA, ALDO O. GONZÁLEZ-CRUZ, XRISTO ZARATE and ISAÍAS BALDERAS-RENTERÍA

Anticancer Research May 2024, 44 (5) 1955-1962; DOI: https://doi.org/10.21873/anticanres.16998
You have access
Patient Age and EGFR-positive Non-small Cell Lung Cancer: A Multicenter Retrospective Study
YOSUKE MAEZAWA, MANATO TAGUCHI, TAKESHI KAWAKAMI, TOSHIHIDE INUI, SHINICHIRO OKAUCHI, TAKESHI NUMATA, TOSHIHIRO SHIOZAWA, KUNIHIKO MIYAZAKI, RYOTA NAKAMURA, KESATO IGUCHI, TAKEO ENDO, TOHRU SAKAMOTO, HIROAKI SATOH and NOBUYUKI HIZAWA

Anticancer Research April 2024, 44 (4) 1751-1757; DOI: https://doi.org/10.21873/anticanres.16974
You have access
Ketamine Promoted Breast Cancer Invasion and Metastasis Through Up-regulating Wnt, BMP, and EGFR Signaling
LI-KUEI CHEN, SHIOU-SHENG CHEN, CHIEN-HUNG SHIH, ZI-XUAN HUANG, LINYI CHEN and KUEN-BAO CHEN

Anticancer Research December 2023, 43 (12) 5415-5424; DOI: https://doi.org/10.21873/anticanres.16745
You have access
YTHDF3 Modulates EGFR/ATK/ERK/p21 Signaling Axis to Promote Cancer Progression and Osimertinib Resistance of Glioblastoma Cells
HSUN-HUA LEE, CHING-CHUAN HSIEH, CHENG-CHIH CHANG, WAN-TING LIAO and HSIANG-CHENG CHI

Anticancer Research December 2023, 43 (12) 5485-5498; DOI: https://doi.org/10.21873/anticanres.16751
Open Access
Cetuximab Enhances the Efficacy of MRTX1133, a Novel KRAS^G12D Inhibitor, in Colorectal Cancer Treatment
MASAHIRO KATAOKA, MASATO KITAZAWA, SATOSHI NAKAMURA, MAKOTO KOYAMA, YUTA YAMAMOTO, SATORU MIYAZAKI, NAO HONDO, HIROKAZU TANAKA and YUJI SOEJIMA

Anticancer Research October 2023, 43 (10) 4341-4348; DOI: https://doi.org/10.21873/anticanres.16629
You have access
Immunohistochemical Analysis of HER2, EGFR, and Nectin-4 Expression in Upper Urinary Tract Urothelial Carcinoma
MAMORU HASHIMOTO, KAZUTOSHI FUJITA, EISUKE TOMIYAMA, SAIZO FUJIMOTO, SHOGO ADOMI, ERI BANNO, TAKAFUMI MINAMI, TETSUYA TAKAO, MASAHIRO NOZAWA, HIROAKI FUSHIMI, KAZUHIRO YOSHIMURA, NORIO NONOMURA and HIROTSUGU UEMURA

Anticancer Research January 2023, 43 (1) 167-174; DOI: https://doi.org/10.21873/anticanres.16146
You have access
Phosphofructokinase 1 Platelet Isoform Enhances VEGF Expression in Part Through HIF-1α Up-regulation in Breast Cancer
JONG-HO LEE

Anticancer Research January 2023, 43 (1) 75-84; DOI: https://doi.org/10.21873/anticanres.16136
You have access
HOXB5 Confers Tamoxifen Resistance in Breast Cancer Cells and Promotes Tumor Aggression and Progression
CLARA YURI KIM, YU CHEON KIM, JI HOON OH and MYOUNG HEE KIM

Anticancer Research July 2021, 41 (7) 3409-3417; DOI: https://doi.org/10.21873/anticanres.15128

Main menu

User menu

Search

EGFR

Pages